Related Experiment Videos
C-Reactive Protein and secondary prevention of coronary events
1Servizio di Cardiologia Ospedale A. Gemelli, Università Cattolica Sacro Cuore, Largo Gemelli, 8, 00168 Rome, Italy. biasucci@pelagus.it
Insights
C-Reactive Protein (CRP) effectively identifies high-risk patients with ischemic heart disease. Measuring CRP alongside cardiac troponins improves risk stratification for acute coronary syndromes, aiding clinical decision-making.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Inflammatory processes are critical in ischemic syndromes.
- C-Reactive Protein (CRP) is a key inflammation marker in ischemic heart diseases like unstable angina and acute myocardial infarction.
Purpose of the Study:
- To evaluate the role of CRP in risk stratification for patients with ischemic heart disease.
- To determine if CRP measurement adds value to cardiac troponins in assessing coronary event risk.
Main Methods:
- Analysis of patient data to assess CRP levels in relation to in-hospital risk.
- Comparison of CRP with cardiac troponins for risk stratification in acute coronary syndromes.
Main Results:
- High CRP levels correlate with increased in-hospital risk of major coronary events.
- CRP measurement provides additional prognostic information beyond cardiac troponins.
- Elevated CRP with negative troponins occurs in 15% of myocardial infarction patients, indicating a distinct risk profile.
Conclusions:
- CRP is a valuable tool for stratifying risk in patients with ischemic heart disease.
- Combined assessment of CRP and troponins enhances the prediction of adverse cardiac events.
- CRP identifies a subset of myocardial infarction patients who may be missed by troponin testing alone.
Abstract:
Accumulating data suggest that in ischemic syndromes, the activation of the inflammatory process plays a critical role. C-Reactive Protein (CRP) is a useful marker of inflammation in patients with ischemic heart diseases, particularly unstable angina (UA) and acute myocardial infarction. CRP may separate patients into two groups, one with low CRP levels and low in-hospital risk and one with high CRP levels and high in-hospital risk of major coronary events. When considering risk stratification of patients with acute coronary syndromes, the measurement of CRP seems to add further information to cardiac troponins. The seronegativity of both markers is associated with very low risk of myocardial infarction, while 15% of patients with MI have elevated CRP with negative troponins.